Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,038 | 146 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,228 | 65 | $0 (2024) |
| Lilly USA, LLC | $305.82 | 12 | $0 (2024) |
| PFIZER INC. | $198.30 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $173.85 | 8 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $172.15 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $160.74 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $148.27 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $147.32 | 6 | $0 (2024) |
| Novo Nordisk Inc | $99.56 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $85.30 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $879.46 | 48 | ABBVIE INC. ($277.84) |
| 2023 | $1,188 | 62 | ABBVIE INC. ($487.93) |
| 2022 | $970.91 | 36 | ABBVIE INC. ($461.87) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.71 | General |
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Gastroenterology | ||||||
| 09/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.48 | General |
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Obesity | ||||||
| 08/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PAIN | ||||||
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 06/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: INFECTIOUS DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 154 | 250 | $65,969 | $19,285 |
| 2022 | 3 | 111 | 211 | $50,685 | $16,162 |
| 2021 | 3 | 129 | 206 | $26,262 | $12,030 |
| 2020 | 3 | 122 | 222 | $31,828 | $11,489 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 131 | $38,414 | $10,451 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $13,464 | $5,481 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 68 | $14,091 | $3,353 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 129 | $33,411 | $9,998 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $7,392 | $3,139 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 54 | $9,882 | $3,025 | 30.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 94 | $12,598 | $5,636 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $5,740 | $3,526 | 61.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 81 | $7,924 | $2,868 | 36.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 127 | $20,101 | $6,174 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 33 | 33 | $5,445 | $3,307 | 60.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 62 | $6,282 | $2,008 | 32.0% |
About Kerri Neel, MS FNP
Kerri Neel, MS FNP is a Nurse Practitioner healthcare provider based in York, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023074424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kerri Neel, MS FNP has received a total of $3,038 in payments from pharmaceutical and medical device companies, with $879.46 received in 2024. These payments were reported across 146 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,038).
As a Medicare-enrolled provider, Neel has provided services to 516 Medicare beneficiaries, totaling 889 services with total Medicare billing of $58,966. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location York, ME
- Active Since 04/25/2006
- Last Updated 11/04/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1023074424
Products in Payments
- UBRELVY (Drug) $744.92
- QULIPTA (Drug) $262.00
- VRAYLAR (Drug) $217.80
- JORNAY PM (Drug) $172.15
- JARDIANCE (Drug) $166.81
- TRELEGY ELLIPTA (Drug) $160.74
- MOUNJARO (Drug) $157.37
- Kerendia (Drug) $155.97
- NURTEC ODT (Drug) $149.60
- XIFAXAN (Drug) $148.27
- TRINTELLIX (Drug) $123.93
- INJECTAFER (Drug) $85.30
- COMIRNATY (Biological) $81.18
- Cologuard Collection Kit (Device) $65.11
- VYEPTI (Biological) $64.13
- PAXLOVID (Drug) $47.73
- Wegovy (Drug) $42.41
- EMGALITY (Drug) $33.20
- STIOLTO RESPIMAT (Drug) $28.54
- VYVANSE (Drug) $23.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in York
Mrs. Laurel Pszcolka, Crnp, CRNP
Nurse Practitioner — Payments: $6,125
Kayla Taylor, Crnp, CRNP
Nurse Practitioner — Payments: $4,603
Mallory Evans, Np, NP
Nurse Practitioner — Payments: $4,108
Theresa Mollah, Crnp, CRNP
Nurse Practitioner — Payments: $2,813
Angela Johnson, Crnp, CRNP
Nurse Practitioner — Payments: $2,649
Janice Cartwright, Crnp, CRNP
Nurse Practitioner — Payments: $2,007